文献速递血栓与止血

疫苗诱导免疫性血小板减少症和血栓形成(VITT)的抗PF4检测:来自NEQAS、ECAT和SSC协作研究385个中心的结果

Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide.
PubMed 文献 · J Thromb Haemost · 2022-06-06

该研究通过向500个开展肝素诱导血小板减少症(HIT)检测的中心分发5份VITT患者和1份健康人的冻干样本进行外部质量评估。385个中心返回了抗PF4免疫分析和功能分析结果,显示ELISA法检测抗PF4抗体在确认VITT方面的敏感性优于功能分析和非ELISA方法,快速免疫分析不应用于检测VITT抗体。

要点

  • ELISA法检测抗PF4抗体确认VITT的敏感性优于功能分析,无论功能分析是否针对VITT改良。
  • 快速免疫分析不应被用于检测VITT抗体。
  • 385个中心参与了抗PF4免疫分析和功能分析的结果回报。

核心结论

  • 基于ELISA的方法检测抗PF4抗体在确认VITT方面比功能分析具有更高的敏感性,无论功能分析是否经过VITT特异性改良。
  • 快速免疫分析不应被用于检测VITT抗体。

研究设计与样本

  • 由NEQAS、ECAT和SSC协作开展的外部质量评估(EQA)研究,向500个开展HIT检测的中心分发5份VITT患者和1份健康人的冻干样本。
  • 参与中心使用其本地验证的HIT检测方法,部分参与者额外报告了VITT改良分析的结果。
  • 共385个中心返回了抗PF4免疫分析和功能分析的结果。

主要发现

  • 用于检测所分发样本抗PF4抗体的ELISA法敏感性优于功能分析和非ELISA方法。

临床怎么用

  • 作者认为,基于ELISA的方法检测抗PF4抗体在确认VITT方面比功能分析具有更高的敏感性。
  • 作者认为,快速免疫分析不应被用于检测VITT抗体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine is a well recognized clinical phenomenon. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, raised D-dimer levels and positivity for immunoglobulin G (IgG) anti-platelet factor 4 (PF4) antibodies. OBJECTIVES: A collaborative external quality assessment (EQA) exercise was carried out by distributing five lyophilized samples from subjects with VITT and one from a healthy subject to 500 centers performing heparin-induced thrombocytopenia (HIT) testing. METHODS: Participating centers employed their locally validated testing methods for HIT assays, with some participants additionally reporting results for VITT modified assays. RESULTS: A total of 385 centers returned results for anti-PF4 immunoassay and functional assays. The ELISA assays used in the detection of anti-PF4 antibodies for the samples distributed had superior sensitivities compared with both the functional assays and the non-ELISA methods. CONCLUSION: ELISA-based methods to detect anti PF4 antibodies have a greater sensitivity in confirmation of VITT compared with functional assays regardless of whether such functional assays were modified to be specific for VITT. Rapid immunoassays should not be employed to detect VITT antibodies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Reilly-Stitt C, Jennings I, Kitchen S, et al. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide. J Thromb Haemost. 2022. PMID: 35603519. doi:10.1111/jth.15766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。